metochalcone has been researched along with chalcone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilmore, JM; Hill, RR; Hoong, LK; Hotema, MR; Kunsch, C; Marino, EM; Meng, CQ; Ni, L; Sikorski, JA; Simpson, JE; Skudlarek, JW; Suen, KL; Wasserman, MA; Weingarten, MD; Worsencroft, KJ; Ye, Z; Zheng, XS | 1 |
| Chabert, JF; Ducki, S; Kendall, A; Lawrence, NJ; McGown, AT; Rennison, D; Woo, M | 1 |
2 other study(ies) available for metochalcone and chalcone
| Article | Year |
|---|---|
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.
Topics: Chalcone; Heterocyclic Compounds; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2004 |
Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
Topics: Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Chalcones; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; K562 Cells; Microtubules; Neovascularization, Physiologic; Structure-Activity Relationship; Tubulin Modulators | 2009 |